Clorox manufactures branded household, personal-care and professional hygiene products, including Clorox cleaning products, Glad, Brita, Burt’s Bees and, following its acquisition of GOJO, Purell.
Loading the company summary…
A snapshot of what CLOROX CO /DE/ owns and owes at a point in time.
Read the company’s balance sheet in the original annual reports below.
Browse original filingsSee the original statement for its reporting period, currency, and unit.
3 reports in this collection
| Report period | Filed with SEC | Form | Source |
|---|---|---|---|
| Jun 30, 20240000021076-24-000030 | Aug 8, 2024 | 10-K | Open 10-Ksec.gov |
| Jun 30, 20250000021076-25-000039 | Aug 8, 2025 | 10-K | Open 10-Ksec.gov |
| Jun 30, 20260000021076-26-000034 | Aug 7, 2026 | 10-K | Open 10-Ksec.gov |
Dates describe the filing metadata. Figures and reporting periods should be checked against the original statement. SEC links open in a new tab.
Clorox’s fiscal 2026 combined weaker earnings with a debt-funded expansion into professional hygiene. Sales fell 5% to $6.720 billion and parent-attributable earnings declined to $587 million. Retailers unwound inventory purchased ahead of the ERP transition, but management also cited weaker consumption and higher manufacturing and logistics costs; the decline was not purely shipment timing. GOJO added sales and institutional distribution, while increasing financing and integration demands. Operating cash flow of $612 million included the completed $476 million Glad buyout payment. After capital expenditures, cash generation was below dividends, despite an improvement in the company’s adjusted cash-flow measure. At June 30, 2026, borrowings were $5.068 billion against $143 million of cash. These findings reflect the annual materials filed August 7, 2026, not verified subsequent developments.
Sources: EX-99.1 · 2026-06-30 · 10-K · 2026-06-30
Clorox operates through Health and Wellness, Household, Lifestyle and International. U.S. markets generated 84% of fiscal 2026 sales. Brand strength supports its business, but mature categories face private-label competition and promotional pressure. Walmart accounted for 26% of sales, and the five largest customers generated about half, giving retailers considerable influence over pricing, shelf space and ordering.
The GOJO acquisition closed April 1, 2026, for approximately $2.147 billion of cash consideration, primarily debt-financed. GOJO contributed $211 million of sales and $6 million of parent-attributable earnings through June 30. Its installed dispensers support replenishment demand, not guaranteed revenue. Integration adds institutional customer, working-capital and FDA-regulatory requirements; consideration and working-capital purchase accounting remained provisional.
Sources: 10-K · 2026-06-30 · EX-99.1 · 2026-06-30
Fiscal 2026 sales declined 5%; organic sales fell 8%. Organic sales exclude currency and acquisitions/divestitures, but not ERP shipment timing. Management principally attributes the decline to retailers drawing down advance purchases made in fiscal 2025, while also identifying category weakness. The ERP timing amount and consolidated consumer sell-through change are not disclosed. GOJO kept Health and Wellness sales flat despite an 8% organic decline. Household and Lifestyle sales fell 11% and 14%; International sales rose 5%, partly helped by currency.
Gross margin fell from 45.2% to 42.3% as lower sales and higher manufacturing/logistics costs outweighed part of the savings benefit. GAAP diluted EPS fell 26% to $4.81; fewer diluted shares cushioned the decline. Comparison cuts both ways: fiscal 2026 avoided the prior $118 million VMS disposal loss but lost the benefit of $70 million in prior-year cyber insurance recoveries. Acquisition/integration costs were $58 million, digital transformation expense was $59 million, and interest expense rose to $130 million from $88 million. Non-GAAP adjusted EBIT, excluding acquisition/integration and transformation costs, declined to $1.030 billion from $1.316 billion; it is not GAAP operating profit.
Sources: EX-99.1 · 2026-06-30 · 10-K · 2026-06-30
Operating cash flow fell to $612 million from $981 million, including the $476 million paid March 2, 2026, for P&G’s remaining Glad interest. Lower cash earnings were partly offset by working-capital movements and lower tax payments driven by accelerated deductions—not a lasting tax-rate reduction. Subtracting $207 million of capital expenditures leaves $405 million, below $602 million of dividends. Clorox’s non-GAAP adjusted free cash flow adds back the Glad payment and therefore rose to $881 million from $761 million. That measure is neither profit nor cash available solely for discretionary spending.
GOJO’s $2.104 billion acquisition cash outflow, net of acquired cash, is another presentation of the same acquisition consideration, not an additional purchase price. Clorox now owns all of Glad and retains core royalty-free licenses, but must replace P&G’s ongoing R&D support. Management expects to prioritize debt repayment. On July 31, before the annual filing, it declared a quarterly dividend increase to $1.25 per share, payable August 28; payment is not established by these sources.
Sources: EX-99.1 · 2026-06-30 · 10-K · 2026-06-30
June 30 borrowings of $5.068 billion, excluding leases, compared with $2.488 billion a year earlier. Cash was $143 million, excluding $4 million of restricted cash; current liabilities exceeded current assets by $949 million. Undrawn revolving commitments totaled $1.964 billion: $764 million expires March 5, 2027, and $1.200 billion in March 2030. These are conditional borrowing capacity, not cash. The acquisition term facility was repaid and cancelled after senior-note financing, so it must not be added again to outstanding debt.
Clorox reported compliance with its minimum 4.0-times defined interest-coverage covenant, without disclosing actual coverage or headroom. Disclosed contractual cash requirements include $1.551 billion due in fiscal 2027 across debt payments, purchases and leases. S&P downgraded the company to BBB in February 2026; ratings remained investment-grade. A below-investment-grade downgrade could trigger derivative collateral requests. Liquidity consequently depends partly on future operating cash generation and continued financing access.
Sources: EX-99.1 · 2026-06-30 · 10-K · 2026-06-30
ERP implementation finished in January 2026, but stabilization and expected efficiencies remain execution risks. The approximately $580 million transformation investment is cumulative, not annual capital spending. GOJO remained in the audited consolidated statements but was excluded from the year-end internal-control assessment under the recent-acquisition allowance. The auditor issued unqualified opinions; the exclusion is not itself a material weakness. No material intangible impairment was identified, although the $322 million Burt’s Bees trademark had valuation headroom of 20% or less.
Management expects fiscal 2027 to remain volatile and challenging, with consumer, tariff and geopolitical pressures; synergies and ERP savings are not guaranteed. It expects no significant future costs or additional insurance recoveries from the 2023 cyberattack, not an absence of future cyber risk. Environmental provisions were $28 million, with remediation and counterparty-payment uncertainty potentially increasing exposure. Linda Rendle announced a planned resignation in May, but remained CEO and chair at the August 7 filing; no effective departure date or successor is established here.
Sources: EX-99.1 · 2026-06-30 · 10-K · 2026-06-30
USD 6.72 bn
FY2026 · GAAP · consolidated · Attribution: consolidated · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2026 | USD 6.72 bn | -5.4% |
| 2025 | USD 7.104 bn | 0.2% |
| 2024 | USD 7.093 bn | — |
Consolidated net sales, net of trade promotion consideration.
Sources: EX-99.1 · 2026-06-30
USD 587 m
FY2026 · GAAP · consolidated · Attribution: parent · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2026 | USD 587 m | -27.5% |
| 2025 | USD 810 m | 189.3% |
| 2024 | USD 280 m | — |
Consolidated net earnings after deduction of noncontrolling interests.
Sources: EX-99.1 · 2026-06-30
USD 612 m
FY2026 · GAAP · consolidated · Attribution: consolidated · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2026 | USD 612 m | — |
GAAP operating cash flow; FY2026 includes the $476 million Glad venture payment.
Sources: EX-99.1 · 2026-06-30
USD 981 m
FY2025 · GAAP · consolidated · Attribution: consolidated · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2025 | USD 981 m | 41.2% |
| 2024 | USD 695 m | — |
GAAP operating cash flow.
Sources: EX-99.1 · 2026-06-30
Reading times are estimates for the English text. Financial tables and charts may take additional time.
